🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/10/1992 20,87 21,17 20,81 20,93 +1,15% 1,71% 5.514.995
29/10/1992 20,69 20,99 20,40 20,69 -0,29% 2,88% 4.973.389
28/10/1992 20,57 20,75 20,52 20,75 +0,87% 1,16% 4.947.189
27/10/1992 20,69 20,75 20,34 20,57 +0,29% 2,02% 4.561.944
26/10/1992 19,62 20,52 19,62 20,52 +4,56% 4,56% 5.458.403
23/10/1992 19,80 19,86 19,38 19,62 -1,50% 2,41% 7.681.211
22/10/1992 20,04 20,04 19,68 19,92 -0,60% 1,79% 5.459.661
21/10/1992 19,86 20,16 19,56 20,04 -0,30% 3,00% 12.288.010
20/10/1992 21,29 21,41 20,04 20,10 -4,80% 6,44% 8.331.181
19/10/1992 20,34 21,11 20,22 21,11 +4,12% 4,40% 6.010.909
16/10/1992 20,87 20,93 20,22 20,28 -3,13% 3,43% 8.080.499
15/10/1992 20,57 21,17 20,57 20,93 +0,86% 2,90% 5.105.437
14/10/1992 20,40 21,05 20,34 20,75 +2,05% 3,51% 6.387.979
13/10/1992 19,86 20,52 19,74 20,34 +2,10% 3,90% 7.532.186
12/10/1992 19,74 20,16 19,74 19,92 +1,52% 2,11% 6.735.496
09/10/1992 20,16 20,22 19,62 19,62 -2,66% 2,96% 5.668.842
08/10/1992 20,28 20,40 19,92 20,16 -0,30% 2,35% 5.973.810
07/10/1992 20,28 20,52 20,04 20,22 +0,00% 2,35% 4.768.819
06/10/1992 20,57 20,63 19,98 20,22 -1,17% 3,19% 6.357.378
05/10/1992 20,28 20,52 19,32 20,46 -0,29% 5,88% 9.872.370
02/10/1992 21,05 21,17 20,46 20,52 -2,55% 3,40% 5.977.582
01/10/1992 21,35 21,47 20,99 21,05 -0,84% 2,23% 5.394.685
30/09/1992 21,23 21,35 21,05 21,23 +1,14% 1,40% 4.579.131
29/09/1992 20,57 21,17 20,52 20,99 +1,73% 3,19% 5.525.475
28/09/1992 20,63 20,69 20,16 20,63 -1,14% 2,60% 7.992.467
25/09/1992 21,47 21,53 20,16 20,87 -4,11% 6,39% 12.468.056
24/09/1992 22,19 22,24 21,53 21,77 -2,41% 3,23% 9.203.117
23/09/1992 22,19 22,36 22,13 22,30 +0,27% 1,08% 3.167.685
22/09/1992 22,24 22,42 22,07 22,24 +0,27% 1,61% 4.257.605
21/09/1992 22,48 22,60 22,13 22,19 -1,85% 2,12% 4.815.350